baber/WOPTO huggingface dataset:
Patent NZ-227931-A (NZ)
Title: Winding fibre material into plurality of wrappings
Inventor: KRUMMENACHER BRUNO
IPC: B29C53/82
Filed: 1989-02-10
Abstract: The winding device 1 has a rotational axis 3 and two side walls 5, 7 arranged perpendicular to the rotational axis. Each side wall 5, 7 is provided with two slits 9a, 9b; 11a, 11b extending from the middle portion 10, 12 to both extreme ends of the side wall substantially parallel to the edges of the side wall. A supply of bolts 21a, 21b, 21c is arranged to the winding device whereby the bolts have a smaller diameter than the width of the slits 9a, 9b; 11a, 11b and a greater length than the distance between the two side walls 5, 7.
Patent NZ-231907-A (NZ)
Title: Transdermal therapeutical system for administering physostigmine
Inventor: HILLE THOMAS
IPC: A61L15/16
Filed: 1989-12-20
Abstract: The invention relates to a transdermal therapeutic system for administering physostigmine onto the skin, composed of a covering layer which is impermeable to the active ingredient, of an adhesive reservoir layer and, where appropriate, of a protective layer which can be detached again, a reservoir layer of which contains 10 - 90 % by weight of polymer material selected as from the groups consisting of block copolymers based on styrene and 1,3-dienes, polyisobutylenes, acrylate- and/or methacrylate-based polymers and esters of hydrogenated rosin, 0-30 % by weight of plasticisers based on hydrocarbons and/or esters and 0.1 - 20 % by weight of physostigmine.
Patent NZ-241108-A (NZ)
Title: Use of insulin-like growth factor and medicaments thereof in promoting cardiac muscle synthesis and preventing/treating heart disorders
Inventor: GLUCKMAN PETER
IPC: A61P9/00
Filed: 1991-12-20
Abstract: The invention discloses the use of human IGF-I or effective analogues thereof for the manufacture of a medicament for prevention or treatment of cardiac disorders. More specifically the medicament is used for the promotion of cardiac muscle protein synthesis, for prevention or treatment of cardiomyopathies, acute heart failure or acute insult including myocarditis or myocardial infarction and for improving of cardiac output by increasing heart stroke volume e.g. for treatment of myocardial infarction. The invention also discloses a composition comprising human IGF-I or effective analogues thereof together with additional proteins or peptides such as other growth factors, hormones, binding proteins or receptors for enhancing or improving the desired effect(s) of IGF-I or its effective analogues and possibly pharmaceutically acceptable carrier or diluent for the prevention or treatment of cardiac disorders.
Patent NZ-248151-A (NZ)
Title: Analysis of medical sample components using neural network
Inventor: SCHAEFER RAINER
IPC: G06F15/80
Filed: 1993-07-15
Abstract: Method for analysing a component of a medical sample by means of an automatic analyser, in which a reaction of the sample is carried using a reagent system and a physically detectable measured variable X resulting from the reaction of the sample with the reagent system is measured in order to determine at least one measured value R for a specific sample, and in which the at least one measured value R is further processed in a processing step by means of a processing unit in order to determine an analytical result A therefrom. According to the invention, in the processing step use is made of the results of neural network training in which for a plurality of standard samples for which the analytical result A is known in each case at least one measured value or one measurement result derived from a plurality of measured values Ri is applied to the input of a neural network, and the analytical result A or a known auxiliary variable combined with the analytical result is applied to the output of the neural network.
Patent NZ-265884-A (NZ)
Title: Apparatus for monitoring impending faults in a component using a constant vacuum
Inventor: DAVEY KENNETH JOHN
IPC: G01M3/26
Filed: 1994-05-06
Abstract: PCT No. PCT/AU94/00235 Sec. 371 Date Sep. 29, 1995 Sec. 102(e) Date Sep. 29, 1995 PCT Filed May 6, 1994 PCT Pub. No. WO94/27130 PCT Pub. Date Nov. 24, 1994A monitoring apparatus for monitoring impending faults in the integrity of a component or structure in static or dynamic application. The apparatus includes a sealed cavity on or within the component or structure connected to a source of constant vacuum. The connection between the cavity and the source incorporates a device of high impedance fluid flow and a monitor for monitoring the change in pressure between the cavity and the source.
Patent NZ-283146-A (NZ)
Title: Drive device for vacuum circuit breakers, disconnection tripping shaft wiping contact actuated only during disconnection
Inventor: MUCKSCH DIETMAR
IPC: H01H33/666
Filed: 1995-03-23
Abstract: In a known drive arrangement in which the switching-off process is initiated after actuation, for example, of an electromagnet by a pin secured to an "off"-trigger shaft as a result of rotation of the latter, thereby enabling a roller of the switching lever to run past the "off"-trigger shaft, the switching-off process occurs when the switching lever has rotated back and the articulated lever systems have moved out of the extended position. However, as the switching lever moves past, it strikes the "off"-trigger shaft. In order to reduce the resultant wear of the "off"-trigger shaft (6) and to actuate the wiping contact (11') associated with the "off"-trigger shaft (6) only during the switching-off process, so as to attain an even greater number of switching cycles, the switching lever (1) has a circular segment (7) with the peripheral surface (9) of which the "off"-trigger shaft (6) is operationally connected in any position of the switching lever (1). Detachably mounted on the "off"-trigger shaft (6) is a trigger bar (11) for connecting and disconnecting a wiping contact (11'). The drive arrangement can also be used for small oil-volume power circuit breakers.
Patent NZ-311633-A (NZ)
Title: Peptides derived from whey protein with a molecular weight of 200-2,000 daltons
Inventor: CHATTERTON DEREK E W
IPC: A23J3/34
Filed: 1996-06-28
Abstract: PCT No. PCT/DK96/00289 Sec. 371 Date Mar. 24, 1998 Sec. 102(e) Date Mar. 24, 1998 PCT Filed Jun. 28, 1996 PCT Pub. No. WO97/01966 PCT Pub. Date Jan. 23, 1997The present invention relates to a method for industrial production of a peptide preparation having specific specifications by hydrolysis of a protein material, preferably based on whey. The method comprises several steps, which makes it easy to control the method so as to obtain a product which, e.g. because of low mineral content, is well suited for peritoneal dialysis and parenteral feeding. The method gives a high yield.
Patent NZ-318212-A (NZ)
Title: Non-polypeptide imides that inhibits the action of TNF-alpha and phosphodiesterase
Inventor: MULLER GEORGE W
IPC: A61K31/40
Filed: 1996-08-29
Abstract: A compound of the formula as shown are inhibitors of tumor necrosis factor alpha and phosphodiesterase and can be used to combat cachexia, endotoxic shock, retrovirus replication, asthma, and inflammatory conditions. A typical embodiment is 3-Phthalimido-3-(3,4-dimethoxyphenyl)propionitrile. Wherein; Y is-C=N or -C(O)-(CH2)mCH3; m is 0, 1, 2, or 3; R5 is (i) o-phenylene, unsubstituted or substituted with 1 to 3 substituents each selected independently from nitro, cyano, trifluoromethyl, carbethoxy, carbomethoxy, carbopropoxy, acetyl, carbamoyl, carbamoyl substituted with and alkyl of 1 to 3 carbon atoms, acetoxy, carboxy, hydroxy, amino, amino substituted with an alkyl of 1 to 3 carbon atoms, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, or halo; (ii) the divalent residue of pyridine, pyrrolidine, imidizole, naphthalene, or thiophene; (iii) a divalent cycloalkyl of 4-10 carbon atoms, substituted and unsubstituted, alkyl of 1-10 carbon atoms, alkoxy 1-10 carbon atoms, phenyl or halo; (iv) disubstituted vinylene, substituted with nitro, cyano, trifluromethyl, carbethoxy, carbomethoxy; R6 is -CO-, -CH2-, -CH2CO- or -SO2-; R7 is (i) cyclic or bicyclic alkyl of 4 to 12 carbon atoms; (ii) cyclic or bicyclic alkyl of 4 to12 carbon atoms; (iii) pyridyl; (iv) phenyl substituted with one or more substituents each selected independently of the other from nitro, cyano, trifluoromethyl, carbethoxy, carbomethoxy, carbopropoxy, acetyl, carbamoyl, acetoxy, carboxy, hydroxy, amino, straight or branched alkyl of 1 to 10 carbon atoms, straight or branched, alkoxy of 1 to 10 carbon atoms, or halo; (v) benzyl substituted with one to three substituents each selected independently from the group consisting of nitro, cyano, trifluoromethyl, carbethoxy, carbomethoxy, carbopropoxy, acetyl, carbamoyl, acetoxy, carboxy, hydroxy, amino, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 10 carbon atoms, or halo; (vi) naphthyl; or (vi) benzyloxy; and; n has a value of 0, 1, 2, or 3.
Patent NZ-333031-A (NZ)
Title: Moulding bevelled end on catheter, forcing catheter on mandrel into mould with constricted region
Inventor: MUSKATELLO JAMES
IPC: B29C31/08
Filed: 1998-11-26
Abstract: A bevelled end is moulded onto the end of a catheter 9 by placing the catheter on a mandrel 2 and introducing it into a mould 1.  The mould has a tapered inner surface 4, 5 and a constriction 6.  The mould is heated as the catheter is moved into it, so that material from the end of the catheter moves past the constriction, to form a flash 11 as shown.  The mould is allowed to cool so that the flash solidifies, so that when the catheter is removed from the mould, the flash breaks off at the constriction.
Patent NZ-333772-A (NZ)
Title: Apparatus, for weed and plant pest control implement, including a bunsen type burner to heat a vaporisation chamber
Inventor: JOHNSTONE IAN
IPC: A01M15/00
Filed: 1997-07-04
Abstract: Apparatus, for the vaporisation of vaporisable hydrocarbon fuels, in particular liquified petroleum gas (LPG) for use in a combustive weed and plant pest control implement, comprises a vaporiser 30 for vaporising the fuel and a vaporiser heater 60 for supplying vaporisation heat to the vaporiser.  The vaporiser includes a tubular vaporiser housing 36 defining in its interior a vaporisation chamber; a fuel delivery tube 34 extending into the housing and arranged to receive the fuel in liquid form from a fuel storage vessel and deliver it into the chamber; a gas delivery outlet 46 in communication with the chamber and arranged to deliver the fuel in gaseous form for subsequent use; and a liquid fuel metering member 42 including an orifice arranged for limiting to a predetermined amount the flow of liquid fuel into the chamber via the delivery tube.  The heater 60 includes a bunsen type burner arranged to direct (jet nozzle 62) a flame to the housing so as to heat the chamber.  The orifice of the metering member is located at the fuel delivery tube 34 in a zone at the vaporiser housing heated by the vaporiser heater 60.
Patent NZ-333842-A (NZ)
Title: Fluorinated 1,4-disubstituted piperidine derivatives, preparation and use as M3 receptor inhibitors
Inventor: TSUCHIYA YOSHIMI
IPC: C07D401/06
Filed: 1999-01-28
Abstract: Fluorine-containing 1,4-disubstituted piperidine derivatives represented by the general formula [I] and pharmaceutically acceptable salts thereof, wherein, Ar represents an aryl group or a heteroaryl group having 1 to 2 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur (any 1 to 3 hydrogen atoms on the ring of said aryl or heteroaryl group may be substituted with lower alkyl, trifluoromethyl, cyano, hydroxyl, nitro, lower alkoxycarbonyl, halogen, lower alkoxy, amino or lower alkyl-amino), R1 represents C3-C6 cycloalkyl whose any 1-4 hydrogen atoms may be substituted with fluorine atoms, R2 represents C5-C15 saturated or unsaturated aliphatic hydrocarbon groups whose any 1 to 6 hydrogen atoms may be substituted with fluorine atoms, aralkyl, arylalkenyl, heteroarylalkyl or heteroarylalkenyl group having 1 to 2 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur (optionally any 1 to 3 hydrogen atoms on the ring in said aralkyl, arylalkenyl, heteroarylalkyl or heteroarylalkenyl group may be substituted with lower alkyl, trifluoromethyl, cyano, hydroxyl, nitro, lower alkoxycarbonyl, halogen, lower alkoxy, amino or lower alkylamino) and, X stands for O or NH, provided that at least either one of R1 and R2 contains one or more fluorine atoms. Pharmaceutical compositions that comprise the abovementioned compounds are also described. These compositions are useful for the treatment or prophylaxis of diseases associated with muscarinic M3 receptors.
Patent NZ-504371-A (NZ)
Title: Dihydropyridine derivatives useful as potassium channel openers
Inventor: CARROLL WILLIAM A
IPC: A61P25/08
Filed: 1998-12-16
Abstract: A pyridine derivative or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof has the formula I wherein: R1 is alkyl; R2 is optionally substituted aryl or heteroaryl; n is 0-2; A is hydrogen, alkyl or -X-R3; R3 is alkyl or haloalkyl; X is -C(O)- or -S(O)p-; p is 1 or 2; R4 and R5 are independently hydrogen, alkyl or haloalkyl or R1 and R5 together with the ring to which they are attached form a 5-, 6- or 7-membered sulfur-containing ring with 1-2 double bonds and 0-2 oxo substituents; or A and R4 together with the ring to which they are attached form a 5-, 6-, or 7-membered carbocyclic ring with 1-2 double bonds and 0-1 oxo substituents or a 5-, 6- or 7-membered sulfur-containing ring with 1-2 double bonds and 0-2 oxo substituents, provided that one of R1 and R5 or A and R4 forms a ring. A cyclopenta[b]thiopyrano[2,3-e]pyridine derivative or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof has the formula II wherein R2 is optionally substituted aryl or heteroaryl; n is 1 or 2; X is -CH2-, -C(O)-, -S(O)-, or -S(O)2- and n' and n" are independently 1 to 3. A pharmaceutical composition thereof is useful for treating asthma, epilepsy, hypertension, Raynaud's syndrome, impotence, migraine, pain, eating disorders, urinary incontinence, functional bowel disorders, neurodegeneration or stroke.
Patent NZ-508736-A (NZ)
Title: Prevention of migraine recurrence using a 5-HT1B/1D receptor agonist such as eletriptan
Inventor: JACKSON NEVILLE COLIN
IPC: A61K31/403
Filed: 1999-06-14
Abstract: Use  of  eletriptan, or a pharmaceutically  acceptable salt  or  composition  thereof, for  the  manufacture  of  a medicament  for  the prevention of migraine  recurrence  and the   use   of   a   5-HT1B/1D  receptor   agonist,   or   a pharmaceutically  acceptable salt  or  composition  thereof, for  the  manufacture  of  a  dual-,  sustained-,  delayed-, controlled-  or  pulsed-release  pharmaceutical  composition for the prevention of migraine recurrence is disclosed.
Patent NZ-509407-A (NZ)
Title: Hybrid electrical-optical cable for overhead installations
Inventor: ZACCONE ERNESTO
IPC: H01B11/22
Filed: 1999-07-16
Abstract: Hybrid electrical-optical cable for overhead installations for power distribution and for telecommunications, comprising three insulated phase conductors helically wound around a supporting rope. Inside the supporting rope there is at least one optical fibre element fitted in a tubular structure which resists transverse compression, a supporting structure resistant to longitudinal tension being present around the said tubular structure.
Patent NZ-511180-A (NZ)
Title: Call handling method
Inventor: VALENTINE MILES JEFCOATE
IPC: H04M1/72457
Filed: 2001-04-19
Abstract: A call handling method for a voice messaging system includes: receiving an caller identifier associated with an incoming call which has not been accepted by the called number; matching the caller identifier with one of a plurality of predetermined caller identifiers, and implementing a caller profile associated with the caller identifier so that the incoming caller receives a designated one of a plurality of pre-recorded voice messages and otherwise implementing a default caller profile providing a default voice message.
Patent NZ-515920-A (NZ)
Title: Multi-purpose hand-held implement of the pocket-knife type for office functions with stapler, punch, and scissors
Inventor: ACKERET PETER
IPC: B25C5/16
Filed: 1996-07-29
Abstract: A multifunction office implement includes a stapler and a puncher in a body of two parts mutually pivoting on an axis between a material receiving open position or second position and a material processing closed or first position.  The stapler includes a staple magazine, a staple driver, a staple anvil and an actuation element, and the puncher includes a punch, a hole die and an actuation element, the staple anvil and the hole die being on the lower body part that serves as a support stage for the material to be stapled or punched.  Material to be stapled or punched can be inserted into the implement when the parts are yawned opened and then punched or stapled as the parts are pivoted together.  The parts may be held releasably latched in the closed or first position.  The implement includes a scissors cutter.
Patent NZ-521826-A (NZ)
Title: Method of operating a regenerative fuel cell for enhancement of characteristics
Inventor: MORRISSEY PATRICK JOHN
IPC: H01M8/18
Filed: 2001-03-21
Abstract: A regenerative fuel cell comprises two half-cells separated by a cation-exchange membrane. There is a halogen/halide electrolyte in one half of the cell, a sulphide/polysulphide electrolyte in the other half of the cell and cations in both halves of the cell, which act as charge carriers therebetween. The state of charge of the sulphide/polysulphide electrolyte is defined as the ratio of the total number of sulfur atoms which make up all sulphur species present in the sulphide/polysulphide electrolyte to the total number of units of negative charge carried by all sulphur species present in the sulphide/polysulphide electrolyte, one unit of negative charge being equivalent to the charge on an electron. The state of charge of the sulphide/polysulphide electrolyte is in the range of from 1. 8 to 2. 5 for at least a part of the charge/discharge cycle over a plurality of charge/discharge cycles. .
Patent NZ-523869-A (NZ)
Title: Narrow ink jet printhead
Inventor: TORGERSON JOSEPH M
IPC: B41J2/15
Filed: 2001-09-07
Abstract: A narrow ink jet printhead (100) having four columnar arrays (61) of ink drop generators (40) configured for monochrome single-pass printing at a print resolution having a media axis dot spacing that is less than the columnar nozzle spacing of the ink drop generators. The ink jet printhead more particularly includes high resistance heater resistors (56) and efficient FET drive circuits (85) that are configured to compensate for variation in parasitic resistance presented by power traces (86a, 86b, 86c and 86d).
Patent NZ-525388-A (NZ)
Title: Disinfectant agent
Inventor: LICHTENBERG FLORIAN
IPC: A61P31/02
Filed: 2001-09-18
Abstract: Disclosed is a disinfectant composition comprising: (a) at least one amine of formula (I), wherein R1 is C6-8-alkyl, (b) at least one guanidinium salt of formula (II), wherein X- is a monovalent anion or one equivalent of a polyvalent anion of an inorganic or organic acid, in the mass ratio (I):(II) of 20:1 to 1:20.
Patent NZ-526738-A (NZ)
Title: Information point with vertical screen displacement for users of varying height with solid-state real time information transfer
Inventor: CEBALLOS COUNAGO ANTONIO MANUE
IPC: G07F7/00
Filed: 2001-11-27
Abstract: The invention relates to an ergonomic "touristic"-theme information point, said information point or center providing users with "touristic"-theme information and being ergonomic. Said interactive terminals are network- connected to all types of information and are characterized by a "universal interface", which includes vertical movement of the screen and enables comfortable access by all individuals regardless of their height, age and physical handicaps, thereby generating a service that can be accessed by any individual seeking information. Said information point comprises a computer system that can store, provide and offer information and transmit information from the information point to another receiver. The computer system is configured with height and presence sensors and an air pressure ground fixing system.
Patent NZ-527675-A (NZ)
Title: Direction indicator system that is activated and deactivated automatically
Inventor: LOVEGROVE DAVID
IPC: G08B5/38
Filed: 2003-08-19
Abstract: Direction indicator system including direction indicating means adapted to indicate a desired direction of travel and a sensor adapted to sense the position of the direction indicating means. In use, when the sensor senses the direction indicating means within a sensing zone the direction indicating means is deactivated and when the direction indicating means is moved out of the sensing zone the direction indicating means is activated so as to indicate the desired direction of travel. Also described is a method for indicating to oncoming and/or following traffic a user's intended direction of travel, comprising the steps of: i) Attaching direction indicating means to the arms of the user ii) Attaching a sensor to either a user or an object so that the sensor is positioned at a mid point region between the direction indicating means when direction indicating means are in a deactivated mode iii) Moving a user's arm away from the user's body in an outward direction to indicate desired direction of travel and to cause the direction indicating means attached to the moved arm to move out of the sensing zone of the sensor so that the direction indicating means is activated to indicate the desired direction of travel iv) Returning the moved arm toward user's body so that as the direction indicating means enters the sensors sensing zone the direction indicating means is deactivated; and v) Repeating steps (iii) and (iv) for each change of direction during travelling.
Patent NZ-529987-A (NZ)
Title: Characterising polypeptides which includes the use of a lysine selective agent, amine reactive agent and recovering N-terminal peptide fragments
Inventor: THOMPSON ANDREW
IPC: C12Q1/37
Filed: 2002-06-07
Abstract: A method for characterising a polypeptide or a population of polypeptides is described. The method comprises the steps of: (a) contacting a sample comprising one or more polypeptides with a lysine selective agent to cap epsilon-amino groups; (b) optionally reacting the sample of polypeptides with an amine reactive reagent to block alpha-amino groups; (c) digesting the sample of polypeptides with a cleavage reagent to produce peptide fragments; (d) optionally deactivating the cleavage reagent; (e) removing those peptide fragments having uncapped or unblocked amino groups; and (f) recovering the N-terminal peptide fragment or fragments. Also disclosed is a compound of the formula I, with the substituents defined herein. The use of a compound of formula I is described to be for the protection of epsilon-amino groups in peptides and polypeptides.
Patent NZ-530510-A (NZ)
Title: Polymorph A of flibanserin having a melting point of 161oC and a process for its preparation and the use thereof for preparing pharmaceuticals
Inventor: BOMBARDA CARLO
IPC: A61K31/495
Filed: 2002-07-30
Abstract: A crystalline polymorph A (form A) of flibanserin has an endothermic maximum at 161oC which occurs during thermal analysis using DSC. The flibanserin can be prepared by reacting a benzimidazolone comprising a suitable amino protecting group with a piperazine in a suitable solvent selected from water, alcohols, mixtures thereof, polar aprotic solvents and mixtures with water in the presence of a suitable base and then in a second reaction step cleaving the amino protecting group under suitable cleaving conditions. The flibanserin can be used in the manufacture of a medicament for treating diseases wherein compounds displaying affinity for the 5-HT1A and 5-HT2 receptor are useful and in treating depression, schizoprenia, Parkinson, anxiety, sleep disturbances, sexual and mental disorders and age associated memory impairment.